Acne keloid

L12_ACNEKELOID

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — L73.0 Hospital discharge: ICD-9 — 7061D Hospital discharge: ICD-8 — 70611 Cause of death: ICD-10 — L73.0 Cause of death: ICD-9 — 7061D Cause of death: ICD-8 — 70611 2 out of 7 registries used, show all original rules.	61
4. Check minimum number of events None	61
5. Include endpoints None	61
6. Filter based on genotype QC (FinnGen only)	57

Control definitions (FinnGen only)

Control exclude: L12_DISORDSKINAPPENDIX

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: L73
Name in latin: Acne cheloides (scleroticans nuchae)

NAME	L12_ACNEKELOID
CONTROL_EXCLUDE	L12_DISORDSKINAPPENDIX
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	L730
HD_ICD_9	7061D
HD_ICD_8	70611
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	L730
COD_ICD_9	7061D
COD_ICD_8	70611
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Acne keloid based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	511	157	348
Only index persons	476	151	325
Unadjusted period prevalence (%)
Whole population	0.01	0.00	0.01
Only index persons	0.01	0.01	0.01
Median age at first event (years)
Whole population	35.43	37.86	34.35
Only index persons	35.04	38.25	33.56

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	57	25	32
Unadjusted period prevalence (%)	0.01	0.01	0.01
Median age at first event (years)	36.60	40.98	33.17

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
61: Matched controls
610

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

L73.0

ICD-10 Finland

Acne keloid

+∞

77.7

D10BA01

ATC

isotretinoin; oral

15.7

13.2

J01AA07

ATC

tetracycline; systemic

7.5

12.8

L70.0

ICD-10 Finland

Acne vulgaris

65.8

10.0

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

9.1

9.6

L73.8

ICD-10 Finland

Other specified follicular disorders

90.7

7.6

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

5.2

6.6

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

3.9

6.4

149

D07XC01

ATC

betamethasone; topical

7.0

6.2

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3007853) Bacteria identified in Skin by Aerobe culture

4.69

5.81

2.5

1.5

—

(3033658) Prothrombin time (PT) actual/Normal

127

2.47

2.78

2.6

3.2

105.29

96.05

0.90

127

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

179

2.33

2.63

2.0

1.8

91.41

96.68

pmol/l

0.28

(3020682) Albumin/Creatinine [Ratio] in Urine

107

2.47

2.61

5.7

4.2

3.48

8.60

mg/mmol

0.81

(36660697) Celiac disease serology panel - Serum

3.13

2.43

1.2

1.3

—

(3022621) pH of Urine by Test strip

3.67

2.27

4.5

1.9

—

(3000330) Specific gravity of Urine by Test strip

3.81

2.12

2.7

4.3

—

(3012516) Albumin [Mass/volume] in Urine

101

2.28

2.11

5.1

3.6

24.84

698.77

mg/l

0.52

(3028707) Methadone [Presence] in Urine by Screen method

4.43

1.86

3.2

2.2

—

(40760892) CBC W Ordered Manual Differential panel - Blood

236

2.00

1.85

6.3

7.2

—

(3022948) Iron [Moles/volume] in Serum or Plasma

2.39

1.81

2.8

1.6

15.45

14.19

umol/l

0.17

(1001926) Buprenorphine [Presence] in Urine by Screen method

3.03

1.70

2.4

1.6

—

(3037467) Urinalysis macro (dipstick) panel - Urine

321

1.99

1.66

7.0

4.2

—

(3022313) Gas panel - Capillary blood

3.79

1.65

6.6

3.4

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

438

2.27

1.63

5.0

4.2

1.59

1.78

mu/l

0.47

403

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

3.53

1.55

1.0

1.2

—

(3037121) Protein [Mass/volume] in Urine

3.31

1.47

8.8

4.6

0.12

0.11

g/l

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2.09

1.44

2.6

0.70

2.16

e6/l

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

2.27

1.43

3.2

2.8

38.27

30.75

u/l

0.32

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

2.78

1.40

3.0

1.5

—

(3000494) Fungus identified in Specimen by Culture

2.22

1.37

1.5

—

(3021589) Normoblasts [#/volume] in Blood

216

1.77

1.33

10.4

11.0

0.00

e9/l

0.50

178

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

217

1.75

1.30

2.2

2.3

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

500

2.46

1.29

18.8

12.7

139.50

139.66

mmol/l

0.18

487

(40768804) Tissue Pathology biopsy report

190

1.76

1.29

1.7

1.8

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1.97

1.26

2.6

2.4

0.51

0.75

e6/l

—

(40768443) Skin Pathology biopsy report

2.77

1.24

1.2

—

(3006504) Eosinophils/100 leukocytes in Blood

240

1.70

1.19

7.3

7.1

2.49

2.75

0.39

231

(3023368) Bacteria identified in Blood by Culture

123

1.79

1.18

4.4

4.6

—

(3028300) Cannabinoids [Presence] in Urine

2.50

1.17

2.7

1.6

—

(3027008) Opiates [Presence] in Urine

2.50

1.17

2.6

1.6

—

(3016879) Cocaine [Presence] in Urine

2.50

1.17

2.4

1.5

—

(3000764) Benzodiazepines [Presence] in Urine

2.42

1.14

2.6

1.5

—

(3027944) Amphetamines [Presence] in Urine

2.42

1.14

2.6

1.5

—

(3042936) Bacteria identified in Isolate by Culture

1.98

1.14

2.8

1.5

—

(3031040) Bacteria [#/volume] in Urine by Automated count

292

1.68

1.12

6.1

4.3

—

38.67

—

(3011288) Drugs identified in Urine by Screen method

2.50

1.11

3.6

1.9

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

293

1.67

1.09

12.9

12.3

4.01

3.92

e9/l

0.10

261

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2.38

1.05

6.0

5.1

—

(3006315) Basophils [#/volume] in Blood

247

1.62

1.02

7.0

7.1

0.04

e9/l

0.17

226

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

507

2.27

1.01

19.6

12.4

29.40

23.87

mg/l

0.34

388

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

380

1.70

0.99

9.3

7.8

78.63

76.28

u/l

0.22

367

(3044889) 12 lead EKG panel

309

1.61

0.96

3.3

—

(3037522) Nuclear Ab [Titer] in Serum

1.88

0.93

1.1

1.5

—

411.76

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

2.18

0.92

5.2

4.2

4.40

4.69

pmol/l

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.99

0.92

3.9

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1.84

0.89

1.2

1.6

—

(3026008) Bacteria identified in Urine by Culture

115

1.66

0.89

3.7

3.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.03

0.87

1.2

1.0

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

171

1.55

0.82

4.8

2.7

—

(3002256) Pathology report gross observation

1.77

0.82

1.1

1.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

0.00

0.81

0.0

1.3

—

364.53

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

102

1.62

0.77

4.1

3.4

—

(21494755) Public health laboratory ask at order entry panel

0.51

0.74

1.2

1.3

—

(3003338) MCHC [Mass/volume]

447

1.66

0.73

20.6

15.4

337.00

334.18

g/l

1.51

447

(3005322) IgE [Units/volume] in Serum or Plasma

2.00

0.72

1.4

3423.00

164.68

u/ml

—

(3007164) IgA [Mass/volume] in Serum or Plasma

105

1.57

0.68

1.9

1.5

2.91

2.55

g/l

—

(3044640) Blood type and Crossmatch panel - Blood

150

1.50

0.67

1.9

2.1

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

115

1.53

0.65

1.9

2.5

313.88

959.73

ng/l

—

(3002385) Erythrocyte distribution width [Ratio]

441

1.56

0.64

21.8

15.5

13.76

14.61

0.73

436

(3000492) Spirometry study

1.62

0.58

1.3

1.4

—

(3018095) Leukocytes [#/volume] in Urine

173

1.42

0.58

4.7

3.4

23.95

11.11

e6/l

0.30

121

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1.50

0.55

1.4

1.5

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

102

1.48

0.53

1.2

1.5

—

(3022217) INR in Platelet poor plasma by Coagulation assay

199

1.34

0.45

5.4

8.6

1.09

1.13

inr

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1.67

0.44

5.4

2.9

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

1.61

0.43

3.0

3.5

1.22

1.44

mmol/l

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1.56

0.42

1.4

—

(3043409) Potassium [Moles/volume] in Arterial blood

0.00

0.42

0.0

3.4

—

4.00

—

(3018405) Lactate [Moles/volume] in Arterial blood

0.00

0.41

0.0

7.1

—

1.67

—

(40761535) Cells panel - Urine sediment

1.47

0.40

9.2

3.4

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1.42

0.39

7.0

2.4

5.42

5.58

kpa

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.47

0.37

1.8

1.6

—

(40758558) Short blood count panel - Blood

130

1.31

0.33

8.5

8.3

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

121

1.32

0.32

3.0

3.5

18.92

23.10

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1.33

0.32

3.3

1.9

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

103

1.33

0.31

1.7

1.5

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

400

1.25

0.28

3.5

3.3

—

(4035726) Immunohistochemistry procedure

1.34

0.24

1.2

1.4

—

(3012544) pH of Venous blood

1.34

0.24

7.0

2.3

—

(40760888) Immunoglobulin light chains.free panel - Serum

0.00

0.21

0.0

1.7

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

0.00

0.21

0.0

1.8

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(4094501) Cardiovascular stress test using bicycle ergometer

0.00

0.21

0.0

1.2

—

(3037756) Immunofixation for Serum or Plasma

0.00

0.21

0.0

1.4

—

(40768793) Breast Pathology biopsy report

0.00

0.21

0.0

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

0.00

0.21

0.0

1.2

—

(3022145) Colonoscopy Study observation

1.25

0.21

1.2

1.3

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1.25

0.21

2.0

1.8

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1.25

0.21

2.0

1.7

—

(36304419) Bacteria [Presence] in Urine

138

1.22

0.20

3.3

2.4

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1.17

0.18

1.6

1.9

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

130

1.20

0.18

2.5

2.1

—

(3003694) ABO and Rh group [Type] in Blood

141

1.18

0.16

1.5

1.3

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.22

0.16

2.1

1.5

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

180

1.17

0.16

3.5

3.0

11.15

25.36

ng/l

3.12

110

(3035350) Ketones [Presence] in Urine by Test strip

233

1.12

0.11

5.3

3.5

0.00

estimate

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

1.07

0.09

4.4

6.4

103.80

104.72

mmol/l

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1.06

0.09

1.8

1.5

—

(3041096) Erythrocytes [Presence] in Urine by Automated

137

1.13

0.08

4.9

3.2

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1.09

0.08

3.5

1.9

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

182

0.91

0.06

5.4

3.5

—

(3013512) EKG study

130

0.90

0.05

5.4

3.5

—

(1761868) Lipid panel - Serum or Plasma

209

0.94

0.03

3.1

2.5

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

108

1.02

0.00

2.4

2.1

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

478

1.02

0.00

18.0

11.2

88.93

89.52

ml/min/173m2

0.07

395

(3011648) Oxygen content in Venous blood

0.00

0.0

2.3

—

11.58

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

0.00

0.0

1.2

—

26.17

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

0.00

0.0

1.7

—

33.00

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

0.0

1.3

—

(3045424) Erythrocytes [Presence] in Urine

0.00

0.0

1.0

—

(21494434) Karyotype in Bone marrow

0.00

0.0

1.0

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

0.00

0.0

1.3

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.0

—

(21494890) Protein electrophoresis panel - 24 hour Urine

0.00

0.0

1.3

—

(3044941) Cell count panel - Synovial fluid

0.00

0.0

1.3

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

0.00

0.0

1.0

—

60.22

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

0.00

0.0

1.2

—

105.45

—

(4146454) Self-monitoring of blood glucose

0.00

0.0

3.0

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.7

—

15.85

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

0.00

-0.00

0.0

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

0.00

-0.00

0.0

2.4

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

1.55

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

0.97

-0.00

2.9

2.3

—

(3023183) Ammonium ion [Moles/volume] in Plasma

0.00

-0.00

0.0

1.2

—

28.56

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.4

—

227.43

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

0.00

-0.00

0.0

1.3

—

15.74

—

(3023410) Appearance of Cerebral spinal fluid

0.00

-0.00

0.0

2.3

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.00

-0.00

0.0

2.4

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

0.00

-0.00

0.0

1.7

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

0.00

-0.00

0.0

1.3

—

(3035285) Chloride [Moles/volume] in Venous blood

0.00

-0.00

0.0

2.4

—

108.78

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

295.39

—

(3000012) Reticulocyte production index

0.00

-0.00

0.0

1.6

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.00

-0.00

0.0

1.6

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.3

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.00

-0.00

0.0

1.9

—

(3005570) Glucose [Moles/volume] in Urine

0.00

-0.00

0.0

1.2

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

0.93

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

2.6

—

15.14

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

0.00

-0.00

0.0

1.8

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

0.00

-0.00

0.0

1.7

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.6

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

3.04

—

(3000093) Morphology [Interpretation] in Blood Narrative

0.00

-0.00

0.0

1.0

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

(3021788) Differential panel - Synovial fluid

0.00

-0.00

0.0

1.4

—

(3028271) Lactate [Moles/volume] in Capillary blood

0.00

-0.00

0.0

3.0

—

1.53

—

(3022806) Fractional oxyhemoglobin in Capillary blood

0.00

-0.00

0.0

2.9

—

88.46

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

0.92

-0.00

2.7

2.2

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.00

-0.00

0.0

1.4

—

(3041354) Potassium [Moles/volume] in Venous blood

0.00

-0.00

0.0

2.4

—

4.01

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.6

—

Mortality – FinRegistry

↥

Association

Association between endpoint L12_ACNEKELOID and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have L12_ACNEKELOID.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: L12_ACNEKELOID – Acne keloid

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Acne keloid

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints